[HTML][HTML] In vitro reversal of direct factor Xa inhibitors: direct comparison of andexanet alfa and prothrombin complex concentrates Cofact and Beriplex/Kcentra
HJM Brinkman, M Zuurveld, JCM Meijers - Research and practice in …, 2022 - Elsevier
Background Both andexanet alfa and four‐factor prothrombin complex concentrate (4F‐
PCC) are clinically applied reversal agents for direct factor Xa inhibitors (FXaIs) in …
PCC) are clinically applied reversal agents for direct factor Xa inhibitors (FXaIs) in …
In vitro reversal of direct factor Xa inhibitors: Direct comparison of andexanet alfa and prothrombin complex concentrates Cofact and Beriplex/Kcentra
HJM Brinkman, M Zuurveld… - … and practice in …, 2022 - researchinformation.amsterdamumc …
Background: Both andexanet alfa and four-factor prothrombin complex concentrate (4F-
PCC) are clinically applied reversal agents for direct factor Xa inhibitors (FXaIs) in …
PCC) are clinically applied reversal agents for direct factor Xa inhibitors (FXaIs) in …
In vitro reversal of direct factor Xa inhibitors: Direct comparison of andexanet alfa and prothrombin complex concentrates Cofact and Beriplex/Kcentra
HJM Brinkman, M Zuurveld… - Research and Practice …, 2022 - Wiley Online Library
Background Both andexanet alfa and four‐factor prothrombin complex concentrate (4F‐
PCC) are clinically applied reversal agents for direct factor Xa inhibitors (FXaIs) in …
PCC) are clinically applied reversal agents for direct factor Xa inhibitors (FXaIs) in …
[HTML][HTML] In vitro reversal of direct factor Xa inhibitors: Direct comparison of andexanet alfa and prothrombin complex concentrates Cofact and Beriplex/Kcentra
HJM Brinkman, M Zuurveld… - Research and Practice in …, 2022 - ncbi.nlm.nih.gov
Background Both andexanet alfa and four‐factor prothrombin complex concentrate (4F‐
PCC) are clinically applied reversal agents for direct factor Xa inhibitors (FXaIs) in …
PCC) are clinically applied reversal agents for direct factor Xa inhibitors (FXaIs) in …
In vitro reversal of direct factor Xa inhibitors: Direct comparison of andexanet alfa and prothrombin complex concentrates Cofact and Beriplex/Kcentra
HJM Brinkman, M Zuurveld… - Research and practice …, 2022 - pubmed.ncbi.nlm.nih.gov
Background Both andexanet alfa and four-factor prothrombin complex concentrate (4F-PCC)
are clinically applied reversal agents for direct factor Xa inhibitors (FXaIs) in emergency …
are clinically applied reversal agents for direct factor Xa inhibitors (FXaIs) in emergency …
In vitro reversal of direct factor Xa inhibitors: Direct comparison of andexanet alfa and prothrombin complex concentrates Cofact and Beriplex/Kcentra.
HJM Brinkman, M Zuurveld… - Research and Practice in …, 2022 - europepmc.org
Background Both andexanet alfa and four-factor prothrombin complex concentrate (4F-PCC)
are clinically applied reversal agents for direct factor Xa inhibitors (FXaIs) in emergency …
are clinically applied reversal agents for direct factor Xa inhibitors (FXaIs) in emergency …
In vitro reversal of direct factor Xa inhibitors: Direct comparison of andexanet alfa and prothrombin complex concentrates Cofact and Beriplex/Kcentra
HJM Brinkman, M Zuurveld… - Research and Practice …, 2022 - search.proquest.com
Background Both andexanet alfa and four‐factor prothrombin complex concentrate (4F‐
PCC) are clinically applied reversal agents for direct factor Xa inhibitors (FXaIs) in …
PCC) are clinically applied reversal agents for direct factor Xa inhibitors (FXaIs) in …
[HTML][HTML] In vitro reversal of direct factor Xa inhibitors: Direct comparison of andexanet alfa and prothrombin complex concentrates Cofact and Beriplex/Kcentra
HJM Brinkman, M Zuurveld… - Research and Practice in …, 2022 - rpthjournal.org
Background Both andexanet alfa and four‐factor prothrombin complex concentrate (4F‐
PCC) are clinically applied reversal agents for direct factor Xa inhibitors (FXaIs) in …
PCC) are clinically applied reversal agents for direct factor Xa inhibitors (FXaIs) in …